The VALIDATE Network - Vaccine development for complex intracellular neglected pathogens
7 - 9 November 2022
Optimmunize: Improving the beneficial effects of vaccines.
Eminent international research scientists, policy makers, journal editors and major foundations to engage in discussions surrounding non-specific and sex-differential effects of vaccines.
In 2020, just before the pandemic hit, the world’s 1st conference on non-specific and sex-differential effects of vaccines was held in Cambridge, UK: Optimmunize: Improving the beneficial effects of vaccines (read more).
We had 100 participants from around the world and our meeting was heralded as a great success: the evaluations were overwhelmingly positive; many expressed that it was the best conference they had attended in years.
At that 2020 meeting we discussed whether vaccines exhibiting beneficial non-specific effects have a role to enhance immunity in the interim ahead of SARS-CoV-2-specific vaccine availability. Subsequently, many of us who had attended the conference initiated randomized trials to test this hypothesis; results are anticipated in the coming months.
There have been other exciting developments in the field that emphasize the need for a follow-up conference. Accordingly, we are now planning for
‘Optimmunize 2022’ to take place in Denmark, at the Danish Institute for Advanced Study at the University of Southern Denmark, from November 9-11, 2022.